No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 7 of the 31 quarters in the window, leaving 24 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 16.9x · 10Y median 23.7x · 37th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 31
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T13:20:36.587Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Amesite Inc. (AMST) stock was $0.94 as of Oct 5, 2026, 4:00 PM EDT, up 0.23% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -70.2% · 3-year avg -27.9%/yr · 5-year avg -45.9%/yr
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation.
Software - Application · Detroit, MI
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.18
vs Estimate
$-0.96
Revenue
$79100.00
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AMST | $6.17M | $0.94 | +0.23% | -70.20% | -45.94% | N/A | N/A |
| 2CHAI | $6.22M | $0.28 | -0.42% | N/A | N/A | N/A | vs AMST |
| 3QCLS | $5.57M | $0.68 | -9.02% | -88.04% | N/A | N/A | vs AMST |
| 4GDC | $5.49M | $1.32 | -7.69% | -99.91% | -83.03% | -64.14% | vs AMST |
| 5IFBD | $6.89M | $0.84 | -2.49% | -18.19% | -84.16% | N/A | vs AMST |
| 6DTSS | $7.10M | $0.68 | -19.03% | -65.86% | -52.67% | N/A | vs AMST |
N/A
vs Estimate
$250000.00
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.94
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.96 | $-0.96 | $-0.96 | 1 |
| Quarter ending Dec 2026 | $-0.84 | $-0.84 | $-0.84 | 1 |
| Quarter ending Mar 2027 | $-0.72 | $-0.72 | $-0.72 | 1 |
| Quarter ending Jun 2027 | $-0.72 | $-0.72 | $-0.72 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $250000.00 | $250000.00 | $250000.00 | 1 |
| Quarter ending Dec 2026 | $484000.00 | $484000.00 | $484000.00 | 1 |
| Quarter ending Mar 2027 | $758000.00 | $758000.00 | $758000.00 | 1 |
| Quarter ending Jun 2027 | $1.03M | $1.03M | $1.03M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
